[Hyperuricaemia and metabolic syndrome in obese children and adolescents]. 2016

Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
Departamento de Pediatría, Facultad de Medicina Campus Centro, Universidad de Chile, Santiago, Chile. Electronic address: ccastd@med.uchile.cl.

BACKGROUND Hyperuricaemia has been suggested as an additional metabolic factor in adult obese patients, but it has not been sufficiently studied in paediatric. OBJECTIVE To assess the relationship between serum uric acid levels (SUAL) with the level of general and visceral obesity, and other biochemical parameters in children and adolescents of Santiago, Chile. METHODS A cross sectional study was conducted on 770 children and adolescents (ages: 6-15 y.) from a public school in Santiago, Chile, of whom 227 (29%) were obese (BMI>2 SD, WHO growth standards). Ninety subjects were randomly selected and 77 with no other chronic disease (41 males) accepted to participate. Data was collected on weight, stature, abdominal circumference (AC), visceral adiposity using ultrasound, and other biochemical measurements including fasting glucose, insulin, serum lipids, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and SUAL. RESULTS The mean SUAL was 0.200±0.065 mmol/L, and was increased in children with hyperinsulinism (adjusted by age: 0.221±0.075 vs. 0.183±0.054 mmol/L; P<.01), with no significant differences according to HOMA. Differences were also found between children with ALT>or<26 U/mL: 0.238±0.070 vs. 0.178±0.054 mmol/L, P<.001. The logistic regression showed the increased SUAL was only associated with increased ALT. No significant differences were found in general or visceral adiposity measurements or fatty liver. CONCLUSIONS Children and adolescents from Santiago, Chile have higher uric acid serum uric acid levels as well as an association with increased ALT and insulin. It is demonstrated in this study that uric acid should be measured in obese children and adolescents, and in their follow up.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002677 Chile A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru.
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
January 2012, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
August 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
January 2012, La Tunisie medicale,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
July 2018, Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki),
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
January 2015, Vnitrni lekarstvi,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
December 2006, Pediatric endocrinology reviews : PER,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
December 2009, Metabolic syndrome and related disorders,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
June 2006, Diabetes research and clinical practice,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
February 2010, Pediatric diabetes,
Carlos Castillo-Durán, and Cecilia Sepúlveda A, and Aníbal Espinoza G, and María Jesús Rebollo G, and Catalina Le Roy O
August 2009, Acta bio-medica : Atenei Parmensis,
Copied contents to your clipboard!